Posts Tagged ‘diabetes’

Oral Semaglutide: Diabesity Business As Usual Is Doomed

February 23, 2018 — Wachet auf! As if the clues were not already present, an announcement yesterday makes it plain. Competitors in the sleepy diabesity market had best wake up. The first ever oral GLP-1 agonist for diabetes and obesity – semaglutide – is looking good in clinical trials. That means everyone else had better get serious about innovation. Or risk becoming […]

Weight Loss Surgery: The False Stigma of an Easy Way Out

February 13, 2018 — An unfounded stigma surrounds weight loss surgery. This prejudice has its primary roots in forgivable ignorance about the reality of a body’s resistance to weight loss. A widespread view is that obesity is a chosen way of life, not an actual disease. The Pattern of a Disease The World Obesity Federation recently published a statement […]

Setting a Goal to Reverse Type 2 Diabetes

December 8, 2017 — Sensational headlines have been hiding a serious story this week. NBC tells us that diet shakes and dropping sodas can reverse diabetes. But behind those headlines lies an important study and an even more important concept. Obesity care specialists and researchers are finding ways to reverse type 2 diabetes through better clinical care. To be […]

Semaglutide Approved for Type 2 Diabetes

December 6, 2017 — Late yesterday, a new, once-weekly injection for type 2 diabetes cleared the hurdle of FDA approval for sale. Semaglutide, will be available early next year in a familiar pen injection device. It will come in two doses: 0.5 and 1.0 mg once weekly. For people with type 2 diabetes it’s great to have a once-weekly […]

Finding More Diagnoses of Type 2 Diabetes Is No Problem

October 27, 2017 — It’s been a reliable trope about type 2 diabetes for a long time. Supposedly, as much as a third of it goes undiagnosed. But a closer look says that finding more diagnoses of type 2 diabetes isn’t much of a problem any more. In Annals of Internal Medicine, Elizabeth Selvin and colleagues published a careful […]

Will Omega-6 Fats Prevent Type 2 Diabetes?

October 14, 2017 — Health reporters are having fun this week with another observational study. A large analysis of prospective cohorts from all over the world found a strong association between linoleic acid and a lower risk of type 2 diabetes. So naturally, the researchers sent out a press release: Omega-6 Fats May Help Prevent Type 2 Diabetes Is […]

Diabetes Remission: Missed Opportunities

October 4, 2017 — In BMJ, Louise McCombie and colleagues are stirring up an important dialogue. They note that medical records seldom document diabetes remission. Why, they ask? To answer their own question, they say this failure reflects a prevailing bias that type 2  diabetes is incurable. That presumption is a missed opportunity for hope and for better health […]

Monitoring Blood Sugar Without a Drop of Blood

September 29, 2017 — Spilling blood is never a good thing. But for people living with diabetes, pricking a finger and getting a drop of blood is an all-too-frequent ritual. Now, that ritual may start to fade. Late on Wednesday, FDA approved the first system for monitoring blood sugar levels without the need for routine finger sticks. The FreeStyle Libre […]

FDA: Liraglutide Prevents Heart Attacks, Strokes, and CV Deaths

August 28, 2017 — It’s official as of Friday. Liraglutide (Victoza) is not only for treating type 2 diabetes and obesity. FDA now says it also effectively prevents heart attacks, strokes, and cardiovascular deaths. This new information applies to people taking it for diabetes who also have heart disease. A Dramatic, Ongoing Shift in Diabetes Care This news represents […]

High Hopes for a New Diabesity Drug

August 18, 2017 — Call us superstitious. The hopes for a new diabesity drug – semaglutide – are growing higher. And to us, that’s a good news, bad news story. The high hopes are coming from good clinical results for this new GLP-1 agonist in a head-to-head comparison with dulaglutide from Eli Lilly. Dulaglutide is a GLP-1 activator that’s already on […]